While a considerable amount of BRCA1 and BRCA2 mutation (BRCA1/2Mut+) carriers still undergo risk-reducing mastectomy (RRM) only, the number of patients with genetic susceptibility to BC who elect reconstruction after bilateral prophylactic mastectomy (BPM) has increased over the last decade [2–4]. The gene discussed is BRCA1; the disease is breast cancer.